Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Profit After Tax: 2009-2025

Historic Profit After Tax for Aytu Biopharma (AYTU) over the last 17 years, with Jun 2025 value amounting to -$14.2 million.

  • Aytu Biopharma's Profit After Tax rose 33.31% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.7 million, marking a year-over-year decrease of 153.02%. This contributed to the annual value of -$14.2 million for FY2025, which is 10.49% up from last year.
  • Aytu Biopharma's Profit After Tax amounted to -$14.2 million in FY2025, which was up 10.49% from -$15.8 million recorded in FY2024.
  • Aytu Biopharma's 5-year Profit After Tax high stood at -$14.2 million for FY2025, and its period low was -$108.8 million during FY2022.
  • In the last 3 years, Aytu Biopharma's Profit After Tax had a median value of -$15.8 million in 2024 and averaged -$15.7 million.
  • Per our database at Business Quant, Aytu Biopharma's Profit After Tax crashed by 328.02% in 2021 and then skyrocketed by 84.33% in 2023.
  • Over the past 5 years, Aytu Biopharma's Profit After Tax (Yearly) stood at -$58.3 million in 2021, then tumbled by 86.62% to -$108.8 million in 2022, then skyrocketed by 84.33% to -$17.1 million in 2023, then rose by 7.08% to -$15.8 million in 2024, then grew by 10.49% to -$14.2 million in 2025.